Search results

"In lieu of global cooperation and solidarity, pharmaceutical companies are being empowered to act as kingmakers ―deciding who lives and who dies― and using this new-found power to extract subsidies and potentially high prices for new COVID-19 vaccines," said Oxfam today in response to reports that French pharmaceutical company, Sanofi, will prioritize the US for any new COVID-19 vaccine.

“The pharmaceutical industry’s attempt to rubbish the World Health Organisation’s initiative suggests that they care more for profits than people’s health," said Anna Marriott, Health Policy Manager for Oxfam, in response to the World Health Organisation’s call for governments to back a voluntary scheme to share trial data and patents relating to vaccines and treatments for the coronavirus.

Ahead of Christmas, 3.1 million people (807,000 families) are in dire need of humanitarian assistance following the destruction left behind by Super Typhoon Rai that hit the Philippines on 16 -17 December 2021

The EU Council meets Thursday 25 to discuss the European-wide scarcity of COVID-19 vaccines that is sparking a dispute between European countries and the UK. The People’s Vaccine Alliance, supported by more than 50 organisations worldwide, is campaigning for free vaccines for all people around the world. It has spokespeople available for interview. 

Survivors of COVID-19 from 37 countries are among almost 1,000 people who have signed an open letter to pharmaceutical industry leaders calling for a ‘people's vaccine’ and treatments that are available to all – free from patents. The letter comes on the eve of a high-level side event about the pandemic at the UN General Assembly in New York.

84 percent of the International Monetary Fund’s (IMF) COVID-19 loans encourage, and in some cases require, poor countries hard hit by the economic fallout from the pandemic to adopt more tough austerity measures in the aftermath of the health crisis, warned Oxfam today.

In reaction to the Government of India’s decision to refuse renewal of Oxfam India’s Foreign Contribution Regulation Act (FCRA) registration, Amitabh Behar, CEO of Oxfam India said: “The restriction will severely affect our ongoing crucial humanitarian and social work in 16 states across the country.